Characterization of hMLH1 and hMSH2 Gene Dosage Alterations in Lynch Syndrome Patients
- 30 September 2005
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 129 (3), 846-854
- https://doi.org/10.1053/j.gastro.2005.06.026
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Use of Microsatellite Instability and Immunohistochemistry Testing for the Identification of Individuals at Risk for Lynch SyndromeFamilial Cancer, 2005
- Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)New England Journal of Medicine, 2005
- A Founder Mutation of the MSH2 Gene and Hereditary Nonpolyposis Colorectal Cancer in the United StatesJama-Journal Of The American Medical Association, 2004
- Identification and characterization of genomic rearrangements ofMSH2 andMLH1 in Lynch syndrome (HNPCC) by novel techniquesHuman Mutation, 2003
- Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancerBest Practice & Research Clinical Gastroenterology, 2003
- Role of DNA Mismatch Repair Defects in the Pathogenesis of Human CancerJournal of Clinical Oncology, 2003
- Hereditary Colorectal CancerNew England Journal of Medicine, 2003
- The Frequency of Hereditary Defective Mismatch Repair in a Prospective Series of Unselected Colorectal CarcinomasAmerican Journal of Human Genetics, 2001
- Deficient DNA mismatch repair: a common etiologic factor for colon cancerHuman Molecular Genetics, 2001
- MSH2 genomic deletions are a frequent cause of HNPCCNature Genetics, 1998